BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 22740432)

  • 1. Preauricular infratemporal fossa approach for advanced malignant parotid tumors.
    Leonetti JP; Benscoter BJ; Marzo SJ; Borrowdale RW; Pontikis GC
    Laryngoscope; 2012 Sep; 122(9):1949-53. PubMed ID: 22740432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management of epithelial parotid tumours.
    Obaid MA; Yusuf A
    J Coll Physicians Surg Pak; 2004 Jul; 14(7):394-9. PubMed ID: 15279739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected Detection of Parotid Gland Malignancy during Primary Extracapsular Dissection.
    Mantsopoulos K; Velegrakis S; Iro H
    Otolaryngol Head Neck Surg; 2015 Jun; 152(6):1042-7. PubMed ID: 25820585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical prognostic factors in malignant parotid gland tumors.
    Lima RA; Tavares MR; Dias FL; Kligerman J; Nascimento MF; Barbosa MM; Cernea CR; Soares JR; Santos IC; Salviano S
    Otolaryngol Head Neck Surg; 2005 Nov; 133(5):702-8. PubMed ID: 16274796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic endonasal approaches to infratemporal fossa tumors: a classification system and case series.
    Taylor RJ; Patel MR; Wheless SA; McKinney KA; Stadler ME; Sasaki-Adams D; Ewend MG; Germanwala AV; Zanation AM
    Laryngoscope; 2014 Nov; 124(11):2443-50. PubMed ID: 25513678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of nasopharyngeal salivary gland malignancy.
    Schramm VL; Imola MJ
    Laryngoscope; 2001 Sep; 111(9):1533-44. PubMed ID: 11568602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of indeterminate fine-needle biopsy in the diagnosis of parotid malignancy.
    Fundakowski C; Castaño J; Abouyared M; Lo K; Rivera A; Ojo R; Gomez-Fernandez C; Messinger S; Sargi Z
    Laryngoscope; 2014 Mar; 124(3):678-81. PubMed ID: 23929699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curative surgery for recurrent nasopharyngeal carcinoma via the infratemporal fossa approach.
    Choi JY; Lee WS
    Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):213-6. PubMed ID: 15781760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic endonasal transpterygoid transmaxillary approach to the infratemporal and upper parapharyngeal tumors.
    Battaglia P; Turri-Zanoni M; Dallan I; Gallo S; Sica E; Padoan G; Castelnuovo P
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):696-702. PubMed ID: 24457630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parotid tumors: a 10-year experience.
    Lin CC; Tsai MH; Huang CC; Hua CH; Tseng HC; Huang ST
    Am J Otolaryngol; 2008; 29(2):94-100. PubMed ID: 18314019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative parotidectomy for the treatment of parotid cancers.
    Lim YC; Lee SY; Kim K; Lee JS; Koo BS; Shin HA; Choi EC
    Oral Oncol; 2005 Nov; 41(10):1021-7. PubMed ID: 16129655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An evaluation of parotid gland masses].
    Yaşar H; Ozkul H; Verim A; Ilhan E; Kökten N; Dereci G
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(2):70-4. PubMed ID: 17527056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal bone osteoradionecrosis after surgery and radiotherapy for malignant parotid tumors.
    Leonetti JP; Marzo SJ; Zender CA; Porter RG; Melian E
    Otol Neurotol; 2010 Jun; 31(4):656-9. PubMed ID: 20964249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer of the parotid gland; long-term follow-up. A single centre experience on recurrence and survival.
    Cederblad L; Johansson S; Enblad G; Engström M; Blomquist E
    Acta Oncol; 2009; 48(4):549-55. PubMed ID: 19140053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preauricular transmandibular and transzygomatic approach for tumors of the infratemporal fossa revisited.
    Timoshenko AP; Asanau A; Gavid M; Colin V; Martin C; Prades JM
    ORL J Otorhinolaryngol Relat Spec; 2013; 75(4):250-5. PubMed ID: 23921824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoid cystic carcinoma of the parotid with facial nerve invasion.
    Ayadi K; Ayadi L; Daoud E; Mnif Z; Ben Mahfoudh K; Boudawara T; Mnif J
    Tunis Med; 2010 Jan; 88(1):46-8. PubMed ID: 20415214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unusual localization of a recurrent benign parotid tumor in the infratemporal fossa].
    Marsot-Dupuch K; Raveau V; Chouard C
    Ann Radiol (Paris); 1992; 35(6):489-93. PubMed ID: 1300093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Parotid Malignancies—10 Years of Experience.
    Kopeć T; Mikaszewski B; Jackowska J; Waśniewska-Okupniak E; Szyfter W; Wierzbicka M
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1397-402. PubMed ID: 25850920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center.
    Al-Mamgani A; van Rooij P; Verduijn GM; Meeuwis CA; Levendag PC
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):189-95. PubMed ID: 22330990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chondrosarcoma of the skull base: long-term follow-up.
    Brackmann DE; Teufert KB
    Otol Neurotol; 2006 Oct; 27(7):981-91. PubMed ID: 17006349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.